课题基金 / 基金详情

Phase I/II randomized controlled clinical trial of umbilical cord-derived mesenchymal stromal cells in refractory systemic sclerosis

Phase I/II randomized controlled clinical trial of umbilical cord-derived mesenchymal stromal cells in refractory systemic sclerosis
脐带间充质基质细胞治疗难治性系统性硬化症的 I/II 期随机对照临床试验
批准号:
401131
负责人:
Hudson Marie
金额:
$30.71万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2021-08-01

项目摘要

项目成果

Hudson Marie的其他基金

相似基金

相关文献

中文摘要
翻译
系统性硬化症(SSC)是一种以皮肤和内脏器官纤维化、炎症和血管病变为特征的慢性全身性自身免疫性疾病。它与显著的发病率和增加的死亡率有关。这是一种孤儿疾病,
英文摘要
Systemic sclerosis (SSc) is a chronic, systemic autoimmune disease characterized by fibrosis of the skin and visceral organs, inflammation and vasculopathy. It is associated with significant morbidity and increased mortality. It is an orphan disease with
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-criteria decision analysis using 1000Minds to develop consensus weights for classification criteria for scleroderma renal crisis
Meta-Epigenomic Research In Autoimmune Diseases - The M-Eriad Program
CAN-STAR - CAnadian Network for SysTemic Autoimmune Rheumatic diseases
海外基金